Tony Michael Argenbright

Array ( [id] => 151836 [patent_doc_number] => 07678770 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Abuse-resistant amphetamine prodrugs' [patent_app_type] => utility [patent_app_number] => 12/201739 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 86 [patent_no_of_words] => 30377 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678770.pdf [firstpage_image] =>[orig_patent_app_number] => 12201739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564822 [patent_doc_number] => 20090137675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'ABUSE-RESISTANT AMPHETAMINE PRODRUGS' [patent_app_type] => utility [patent_app_number] => 12/202067 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 30374 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137675.pdf [firstpage_image] =>[orig_patent_app_number] => 12202067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 162559 [patent_doc_number] => 07671030 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Abuse-resistant amphetamine prodrugs' [patent_app_type] => utility [patent_app_number] => 12/201950 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 86 [patent_no_of_words] => 30377 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/671/07671030.pdf [firstpage_image] =>[orig_patent_app_number] => 12201950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410801 [patent_doc_number] => 20090124700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'ABUSE-RESISTANT AMPHETAMINE PRODRUGS' [patent_app_type] => utility [patent_app_number] => 12/201982 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 30372 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124700.pdf [firstpage_image] =>[orig_patent_app_number] => 12201982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279401 [patent_doc_number] => 20090131533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'ABUSE-RESISTANT AMPHETAMINE PRODRUGS' [patent_app_type] => utility [patent_app_number] => 12/201586 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 71 [patent_no_of_words] => 30375 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131533.pdf [firstpage_image] =>[orig_patent_app_number] => 12201586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564820 [patent_doc_number] => 20090137673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'ABUSE-RESISTANT AMPHETAMINE PRODRUGS' [patent_app_type] => utility [patent_app_number] => 12/201820 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 30376 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137673.pdf [firstpage_image] =>[orig_patent_app_number] => 12201820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564821 [patent_doc_number] => 20090137674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'ABUSE-RESISTANT AMPHETAMINE PRODRUGS' [patent_app_type] => utility [patent_app_number] => 12/201866 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 30374 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137674.pdf [firstpage_image] =>[orig_patent_app_number] => 12201866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10648285 [patent_doc_number] => 09364513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-14 [patent_title] => 'Compositions and methods for promoting hemostasis and other physiological activities' [patent_app_type] => utility [patent_app_number] => 12/199670 [patent_app_country] => US [patent_app_date] => 2008-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 25227 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12199670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509359 [patent_doc_number] => 20090082566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'ACYCLOVIR-PEPTIDE ANALOGS' [patent_app_type] => utility [patent_app_number] => 12/194248 [patent_app_country] => US [patent_app_date] => 2008-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22011 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082566.pdf [firstpage_image] =>[orig_patent_app_number] => 12194248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5986764 [patent_doc_number] => 20110098254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'COMPOSITIONS COMPRISING PHOSPHOLIPIDS' [patent_app_type] => utility [patent_app_number] => 12/673300 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17002 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098254.pdf [firstpage_image] =>[orig_patent_app_number] => 12673300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199258 [patent_doc_number] => 20120122759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'METHODS FOR REMOVING A CONTAMINANT USING INDIGENOUS PROTEIN DISPLACEMENT ION EXCHANGE MEMBRANE CHROMATOGRAPHY' [patent_app_type] => utility [patent_app_number] => 13/058796 [patent_app_country] => US [patent_app_date] => 2008-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16426 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122759.pdf [firstpage_image] =>[orig_patent_app_number] => 13058796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7756650 [patent_doc_number] => 20120028880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'VEGFR-1/NRP-1 TARGETING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/672647 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16391 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028880.pdf [firstpage_image] =>[orig_patent_app_number] => 12672647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5360466 [patent_doc_number] => 20090035260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'ENHANCED NASAL COMPOSITION OF ACTIVE PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/186251 [patent_app_country] => US [patent_app_date] => 2008-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6114 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035260.pdf [firstpage_image] =>[orig_patent_app_number] => 12186251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9844467 [patent_doc_number] => 08946383 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Obtaining cocoa extracts rich in bioactive peptides with ACE and PEP enzyme inhibitory activity' [patent_app_type] => utility [patent_app_number] => 13/056909 [patent_app_country] => US [patent_app_date] => 2008-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5782 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13056909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316434 [patent_doc_number] => 20090281032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Modified CCK peptides' [patent_app_type] => utility [patent_app_number] => 12/177306 [patent_app_country] => US [patent_app_date] => 2008-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 16071 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281032.pdf [firstpage_image] =>[orig_patent_app_number] => 12177306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5520975 [patent_doc_number] => 20090028956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Polypeptide microparticles' [patent_app_type] => utility [patent_app_number] => 12/215504 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14238 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028956.pdf [firstpage_image] =>[orig_patent_app_number] => 12215504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8458036 [patent_doc_number] => 08293702 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => 'Phenolic binding peptides' [patent_app_type] => utility [patent_app_number] => 12/144572 [patent_app_country] => US [patent_app_date] => 2008-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11084 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12144572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348903 [patent_doc_number] => 20090004264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'METHODS FOR TREATING AND AMELIORATING THE SYMPTONS OF INFLAMMATORY BOWEL DISEASES' [patent_app_type] => utility [patent_app_number] => 12/144266 [patent_app_country] => US [patent_app_date] => 2008-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11539 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004264.pdf [firstpage_image] =>[orig_patent_app_number] => 12144266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 168773 [patent_doc_number] => 07666985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'HLA-A24-restricted cancer antigen peptides' [patent_app_type] => utility [patent_app_number] => 12/142372 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 36 [patent_no_of_words] => 20926 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666985.pdf [firstpage_image] =>[orig_patent_app_number] => 12142372 [rel_patent_id] =>[rel_patent_doc_number] =>)